Get the latest news on Evolutionary Genomics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on FNAM performance

Latest Evolutionary Genomics Stock News | OTC:FNAM | Benzinga

Evolutionary Genomics Inc is involved in the development of a technology platform, the Adapted Traits Platform (ATP), to identify commercially valuable genes that control important traits in animals and plants. It uses the ATP to identify genes to improve crop plant traits such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. The company's platform identifies key genes that have changed successfully to impart new or improved traits. Its primary source of revenue had been contract services revenue for research performed by it on behalf of other commercial entities and grant income received from governmental agencies, industry associations and grant-making foundations for research performed.

EVOLUTIONARY GENOMICS INC by Evolutionary Genomics, Inc.

Comments

Evolutionary Genomics Stock News

News

Latest Evolutionary Genomics Stock News | OTC:FNAM | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga